A porcine cardiac polypeptide fraction in the Khavinson registry, kept here mainly as a thin-literature archive entry beside synthetic cardiogen.
polypeptide fraction · porcine cardiac
porcine cardiac polypeptide fraction
Distinct from synthetic cardiogen (AEDR). Dedicated product literature is thin in our CyberLeninka map.
Cardialin appears in the Khavinson peptide family listing as a cardiac-tissue polypeptide fraction. Corpus text also places it historically for cardiac dystrophy and post-infarct recovery framing in Russian registration language.
It is not the synthetic AEDR tetrapeptide sold as cardiogen. Same programme neighbourhood, different chemistry.
We keep the dossier because the name collision with BNP literature is itself part of the archival problem this shelf documents.
Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.
Synthesis notes that CyberLeninka hits under the cardialin search string are mostly tangential. The closest school-adjacent piece in the mapped set is a peptide pharmacology review that discusses cortexin and cerebrolysin. It does not name cardialin as a product.
BNP / mozgovoy natriureticheskiy peptid diagnostic titles dominate the rest of the retrieval cloud. Those are not about this polypeptide fraction. They are dropped from the paper list below.
What remains after off-topic BNP and unrelated cardiology drops is a near-empty dedicated product trail plus one peptide-pharmacology review.
Absence of open dedicated studies is recorded as an archive fact. It is not treated as proof the product never existed.
1 in corpus · off-topic retrieval rows removed (BNP diagnostics, Mexicor arrhythmia, IF-current MI, snake toxin, adrenoreceptor, prevention letters, thiotriazoline)
No PubMed-indexed rows mapped for this entry in the current corpus.
Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.